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1. Introduction 
Infective endocarditis (IE) is a rare affection with an annual incidence of between 15 to 60 
cases per million. If untreated, IE is fatal, and the overall mortality is evaluated above 20%. 
IE is an endovascular microbial infection of intracardiac structures. The early characteristic 
lesion corresponds to variable sized vegetation leading to valvular destruction and abscess 
formation. 
Epidemiologic profile evolved progressively with decreasing proportion of IE on abnormal 
native valve compensated by an increased proportion of prosthetic valve IE and native 
valve IE with previously unrecognized predisposing conditions. Among causative 
microorganisms, the responsibility of staphylococci is more frequently observed. 
Diagnosing IE remains a clinical challenge because evolution is insidious and symptoms are 
polymorphous. This diagnosis must be systematically considered in the presence of 
purpura, distal necrosis but also in patients who had have chronic dermatosis which 
correspond to an underestimated potential source of IE. 
2. Pathophysiology 
Secondary to damage of endothelium, extracellular matrix proteins are exposed leading to 
development of non-bacterial thrombotic endocarditis (NBTE) with fibrin and platelets. 
Endothelial damage can occur after mechanical lesions (devices, repeated intravenous 
injection of particulate material), turbulent blood flow (congenital heart disease, prosthetic 
valves…), inflammation (chronic rheumatic fever) or degenerative lesions (European society 
of cardiology [ESC], 2009). NBTE facilitates micro-organism adherence and infection of 
endothelium (Figure 1). 
International specialists (American Heart Association [AHA], 2007; ESC, 2009) no longer 
differentiate acute, subacute and chronic IE based on usual progression of untreated disease. 
Indeed, although clinical manifestations are more insidious in subacute IE, severe 
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complications can occur and it is currently difficult to determine the onset of the disease. 
Presently, IE are classified depending on the type of valve damage (right/left-sided, 
native/prosthetic valve).  
 
Fig. 1. Pathophysiology of IE with aseptic and septic phases (A. Servy; August 2011). NBTE: 
non- bacterial thrombotic endocarditis 
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3. Epidemiology  
3.1 Incidence 
IE is a rare disease with 2 to 6 per 100 000 persons affected per year (Que, 2011). Classically 
described in young patients after chronic rheumatic heart disease. Its incidence in 
industrialized countries is more elevated in at-risk groups, mainly persons older than 65 years 
old (15 per 100 000 per year). At present, the average is 57 years old (Que, 2011; ESC, 2009). 
Native valve IE is the most frequent. Left-sided native valve IE represents 70% of disease 
incidence and the mortality is evaluated at 15% (25-45% with healthcare-associated). 5-10% 
of IE affect right-sided native valve, mainly in intravenous-drug users, and patients with 
congenital heart disease or devices. Staphylococcus spp is most frequently involved in right-
sided native valve IE and mortality is less than 10% (Que, 2011).  
Prosthetic valve IE is also increasing (10-30% of IE), mechanical and bioprosthetic equally. 
The prevalence of valve prostheses IE is above 6% (0.3-1.2% per year). Left-sided prosthetic 
valve endocarditis (20% of IE) is the most severe with 20 to 40% mortality. The main germs 
involved in early prosthetic valve IE (less than one year after cardiac surgery) include 
staphylococci, fungi and Gram-negative bacilli, whereas late IE is associated with 
staphylococci, oral streptococci, S. bovis and enteroccoci (ESC, 2009). 
3.2 Risk factors  
3.2.1 Characteristics of patient  
The main risk factor is age (median age above 60) (Murdoch, 2009) due to degenerative 
valve, immunosuppressive conditions and multiple comorbidities. However, edentate 
people have a lower risk of IE. Digestive portal of entry is frequent in this population, 
mainly in S. bovis and enterococcus IE and should be researched. 
Many comorbidities increase the risk of IE, leading to heart diseases. At present, in 
industrialized countries, chronic rheumatic heart disease has become  exceptional and the 
proportion of degenerative valve lesion and congenital heart disease is more important  as 
well as their responsibility  for IE (Moreillon, 2004). Chronic immunosuppressive therapy 
(chemotherapy, topical corticosteroid…) or affections are predisposing conditions, mainly 
diabetes mellitus (16% of IE), hemodialysis (8%), cancer (8%) and HIV infection (2%) 
(Murdoch, 2009). Physicians should be aware of the risk of EI in cases of acute or chronic 
dermatosis. Chronic bacteria carriers, wounds, and percutaneous invasive procedure 
increase significantly the risk of bacteremia.  
3.2.2 Situations at risk   
All iatrogenic invasive procedures are at risk of bacteremia such as catheter, urinary 
surgery, and endoscopy (Table 1). Nevertheless, intravenous drug users are more at risk 
(10% of IE) due to poor hygiene. Indeed 55% of active heroin, cocaine and 
methamphetamine injection drug users report a lifetime history of skin infection mainly in 
cases of intramuscular injection or frequent heroin or speedball injection (Phillips, 2010). In 
these cases, S. aureus and fungi must be suspected and treated. Dental treatments are too 
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easily suspected (AHA, 2007; Strom, 1998) whereas most of the time, no procedure or 
situation at risk are identified and daily bacteremia is often involved (AHA, 2007). In a 
recent French study (Association pour l'Etude et la Prévention de l'Endocardite Infectieuse 
[AEPEI], 2002), 63% of IE cases had no situation at risk identified. 
 
Risk factors of IE 
Patient characteristics Situations at risk 
Age  Invasive procedures:  
- percutaneous (drug, catheter…) 
or 
-  dental 
Daily bacteremia 
- Brushing teeth 
- Chewing … 
Comorbidities  Heart disease and prosthetic 
valve 
Diabetes mellitus 
Chronic renal failure 
Immunosuppressive affection 
Treatment Immunosuppressive therapy 
Table 1. Procedures and situations at risk of bacteremia. 
3.3 Causal microorganisms  
Distribution of causative microorganisms of IE is different, depending on the patient’s 
characteristics (Table 2) and portal of entry. Gram-positive bacteria are the most frequent 
microorganisms. They are responsible for more than 80% of IE because they have greatest 
ability to adhere and colonize damaged valves (Que, 2011). 
Microorganisms (%) 
Valve affected 
Native valve IE Intracardiac device IE 
Drug abusers
Others 
patients 
Prosthetic 
valve 
Others 
Staphylococcus aureus 68 28 23 35 
Coagulase-negative 
staphylococcus 
3 9 17 26 
Viridans group streptococci 10 21 12 8 
Streptococcus bovis 1 7 5 3 
Enterococcus ssp 5 11 12 6 
HACEK 0 2 2 1 
Fungi  1 1 4 1 
Polymicromial  3 1 0.8 0 
Negative culture findings 5 9 12 11 
Table 2. Microbiologic etiology of IE depend on patient’s characteristics (Murdoch, 2009). 
HACEK: Haemophilus (parainfluenzae, aphrophilus, paraphrophilus and influenza), 
Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, 
Kingella (kingae and dentrificans). 
Although increasing involvement of oral streptococci, streptococcaceae remain the main 
pathogen (nearly 60% of IE). In streptococci group, group D (S. bovis…) are found in 25%, 
oral streptococci in 17% and pyogenic streptococci (S. agalactiae, S. pyogenes) in 6% of IE. 
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Enterococci (mainly E. faecalis) are also frequent (8%), mainly in elderly people and 
prosthetic valve carriers (AEPEI, 2002). Urinary and digestive portal of entry (including 
colon cancer, and diverticulitis) must be researched with colonoscopy and imaging. 
Presence of S. bovis equally implies digestive portal of entry. 
The role of Staphylococcaceae is increasing (20-34% of IE) with 23% of IE due to S. aureus 
and 6% to coagulase-negative staphylococci (AEPEI, 2002; Miro, 2005). Staphylococcus IE is 
more frequent in intravenous drug users, HIV patients, right-sided IE and iatrogenic 
infection. The prevalence of IE in patients with Staphylococcus aureus bacteremia is elevated 
(22%) and some authors recommend a systematic echocardiography in this situation 
(Rasmussen, 2011).  
The responsibility of others germs is lesser and unusually several microorganisms are 
associated in rare instances (less than 5%). No germ is identified in 5% of cases (AEPEI, 2002). 
3.4 Portals of entry 
Any site of infection can be responsible of IE. However, some portals of entry are more 
frequent and must be investigated. Cutaneous portal of entry is frequent (20%) and often 
misdiagnosed by physicians. In these cases, IE mainly developed on traumatic or chronic 
wounds, infected or inflammatory dermatosis, intravenous drug use, percutaneous 
iatrogenic procedures… Dental portal of entry is observed in 9% of cases (poor dental 
condition, dental procedure). Genitourinary and digestive portal of entry are observed 
respectively in above 2-11% and 5-9% (AEPEI, 2002; Tornos, 2005). 
4. Diagnosis 
4.1 Clinical manifestations   
Clinical diagnosis of IE is often difficult because of various clinical manifestations and 
insidious evolution. Moreover, atypical presentation is usual in elderly, 
immunocompromised patients (lack of fever) and carriers of prosthetic valve, mainly in 
earlier phase (less than one 1 year after surgery). In fact, in this last group, blood cultures are 
frequently negative, echocardiography is difficult (ESC, 2009) and inflammatory syndrome 
and fever is classical even in absence of IE. So, clinical suspicion of IE should be 
systematically discussed in these cases, and complementary investigations performed. 
4.1.1 General signs  
Fever is the most frequent sign (approximately 90%) and usually temperature normalizes 
within 1 week (5-10 days) under adaptive antibiotherapy. An impaired general health 
condition can be observed with weight loss, fatigue and anorexia. 
4.1.2 Cardiological signs 
Cardiological manifestations are nearly constant. Heart murmurs are found in up 85% of IE 
(ESC, 2009) but occurrence of new ones (48%) or increasing of an older murmur (20%) are 
more evocative (Murdoch, 2009). Clinical manifestations of heart complications can be 
added (mainly heart failure). 
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4.1.3 Extracardiac manifestations 
Extracardiac manifestations are also frequent, particularly in right-sided IE (78% versus 52% 
in left-sided IE) with 68% of pulmonary embolism (AEPEI, 2002). 
If IE is suspected, dermatological manifestations should be systematically searched and 
discussed despite rarity (5 to 25% of IE present skin manifestations) not only for diagnosis but 
also for prognostic (Table 5). They can easily lead to suspicion of IE. In our recent study 
(unpublished data), we demonstrated a link between the presence of cutaneous signs and 
embolic events (18.4% of embolic events in lack of cutaneous sign versus 33%) without higher 
mortality. Dermatological manifestations (Figures 2 and 3) seem to be also less frequently 
observed with enteroccoci infection (14.5% versus 27.1%) (Martínez-Marcos, 2009).  
   
Fig. 2. Vascular purpura on trunk and arms during IE. 
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Fig. 3. Necrotic lesions of fingers (same patient): old Janeway lesion or purpura lesion. 
- Osler’s lesions are specific and described as purple painful nodes on palms, soles, 
fingertips, pulp of the toes or sometimes on ears (Farrior, 1976). Unfortunately, 
prevalence is low (3-3.6%) (AEPEI, 2002; Murdoch, 2009) and lesions disappear in a few 
days without sequelae. In a study including 43 intravenous-drug users IE, Osler’s nodes 
were observed in 50% of left-sided IE whereas none were noticed in right-sided IE (33 
right-sided). Moreover, bacteriological study of nodes revealed the same 
microorganisms as in blood (S. aureus). 
- Janeway lesions are small non tender erythematous and painless macular (sometimes 
nodular!) localized on palms or soles (2-5% of IE) (AEPEI, 2002; Murdoch, 2009). These 
lesions are equally specific and their differenciation difference with Osler nodes is often 
as difficult, clinically as histologically. 
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- Purpura is more frequent (7.3%) (AEPEI, 2002) but not specific. Its pathophysiology is 
still unclear including often septic embolism and/or leucocytoclastic cutaneous 
vasculitis by complex immune depositions (Lévesque 1999). Vascular purpura is 
characterized by red lesions that don’t blanch on applying pressure, caused by 
erythrocyte extravasation. Lesions are localized on lower parts of the body (legs, back). 
In IE, lesions are also described on the neck and near the clavicles. IE mucosal purpura 
is often observed on conjunctivae and mouth (Heffner, 1979). 
- Splinter haemorrhages are common in many diseases and found in 8 to 14% of IE 
(Konstantinou, 2009; Murdoch, 2009). 
30% of IE (ESC, 2009) has at least one vascular or immunological phenomenon. Vascular 
phenomenon includes systemic arterial embolism (17-33%) (AEPEI, 2002; Murdoch, 2009), 
infectious embolism (septic pulmonary infarct, infectious aneurysm) and classically Janeway 
lesions. Immunological manifestations are mainly represented by Osler’s nodes and Roth 
spots (2%) (Murdoch, 2009). 
Musculoskeletal symptoms are common with mainly arthralgia (14%) (Murdoch, 2009), 
myalgia and back pain. In the presence of, spondylodiscitis (3-15%) (ESC, 2009) mainly 
observed in streptococci IE must be systemically discussed. Splenomegaly is less frequently 
noticed (11%) (Murdoch, 2009). 
4.2 Laboratory studies  
4.2.1 Biology findings  
- Inflammatory syndrome 
In most cases, unspecific inflammatory syndrome is observed, including neutrophils 
hyperleucocytosis, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein. 
- Microbiological diagnosis 
Three sets of blood cultures, including at least one aerobic and one anaerobic samples and 
spaced of at least 30 minutes, should be obtained from a peripheral vein before beginning 
any antimicrobial therapy. The blood cultures are positive in 85% of cases (ESC, 2009). 
However, blood culture can be negative in cases of prior antibiotherapy or specific 
microorganisms (Table 3). In this last case, other bacteriological investigations are 
performed, such as serologies, specific PCR and culture on surgical material, catheter and 
device (pacemaker, defibrillator…) or embolus samples. 
Negative blood culture
Frequently Constantly: bacteria intracellular 
Fastidious Gram-negative bacilli of HACEK 
group  
Nutritionally variant streptococci 
Brucella  
Fungi  
Coxiella burnetii
Bartonella 
Chlamydia 
Trophynema whipplei 
Table 3. Microorganisms and negative blood culture. HACEK group: Haemophilus 
(parainfluenzae, aphrophilus, paraphrophilus and influenza), Actinobacillus 
actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella (kingae 
and dentrificans). 
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- Rheumatoid factor is an immunological phenomenon, not specific but found in 5% of IE 
(Murdoch, 2009).  
4.2.2 Histologic findings 
Valvular histology after cardiac surgery is the gold standard for diagnosis of IE and 
observed vegetations, microorganisms and/or valvular inflammation (Greub, 2005).  
 
Fig. 4. Cutaneous leucocytoclastic vasculitis (H&E stain; x200). 
Kidney fragments can reveal different unspecific lesions including glomerulonephritis or 
interstitial lesions.  
Skin biopsies for histological study are often performed. Osler’s nodes are classically 
explained by immune complex deposition, mainly responsible of leucocytoclastic vasculitis. 
Janeway lesions are associated with septic emboli; however, all histological findings can be 
observed in both lesions (Cardullo, 1990; Kerr, 1979; Loewe, 2009; Espinosa Parra, 2002).  
4.3 Imaging studies 
4.3.1 Echocardiography  
Echocardiography is the second fundamental examination for IE diagnosis and its heart 
complications. In first-line, transthoracic echocardiography (TTE) must be systematically 
performed in case of suspicion. Its sensibility only ranges from 40 to 63%. So, in cases with 
www.intechopen.com
 
The Cardiovascular System – Physiology, Diagnostics and Clinical Implications 
 
354 
negative examination, poor quality of the exam, prosthetic valve… transoesophageal 
echocardiography (TEE) is recommended if there is high clinical suspicion. In the other 
cases, a second echocardiography must be performed 7-10 days later if suspicion remains 
(ESC, 2009). Evocative signs of IE are vegetations (mobile echogenic masses implanted in the 
endothelium in the trajectory of valvular regurgitation or implanted in prosthetic material), 
abscess and new dehiscence of a valvular prosthesis (Evangelista, 2004). However, 
echocardiography does not permit differentiation between septic and aseptic vegetations; so 
lesions persisting after effective treatment must not be interpreted as a clinical recurrence of 
the disease unless supported by clinical features and bacteriological evidence. 
Echocardiography is repeated as soon as new complications are suspected or at completion 
of antibiotic therapy for evaluation of cardiac and valve function. 
4.3.2 Other imaging 
Computed tomography can be used in second intention to diagnose (good evaluation of 
valvular abnormalities) IE (Feuchtner, 2009) and its systemic complications.  
Magnetic resonance imaging is also useful for detection of complications such as cerebral 
emboli. 
4.4 Duke criteria  
Various manifestations of IE exist and diagnosis is often difficult. Therefore, the Duke 
criteria combining clinical and biological criteria have been proposed (Table 4) (Li, 1999). 
5. Differential diagnoses 
IE is an insidious disease associated with a clinical polymorphism. Differential diagnoses are 
multiple and it is impossible to give an exhaustive list. Suspicion of IE must be 
systematically discussed in cases of unexplained fever until proof of contrary. Note 
echocardiographic differential diagnoses: aseptic vegetations in Libman-Sacks endocarditis 
(in systemic lupus erythematosus and antiphospholipid syndrome) and marantic 
endocarditis associated with gastric and pulmonary adenocarcinoma.  
6. Severe complications 
6.1 Morbidity 
6.1.1 Heart complications  
Heart failure is the most frequent complication (50 to 60% of IE) mainly on aortic native 
valve IE (29%). It can be explained by valve insufficiency after native valve destruction 
causing acute regurgitation (chordal rupture, leaflet rupture or perforation) or prosthesis 
dehiscence. Other causes of heart failure include intracardiac fistulae, myocarditis, 
pericarditis (in S. aureus infection mainly) or valve obstruction by big vegetations. Surgery is 
often indicated (Table 5) in emergency because this complication is the worst predictive 
factor of in-hospital and 6-month mortality. 
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Definition of term used 
Pathologic  
criteria Microorganisms demonstrated by culture or histologic examination of a vegetation, a vegetation that has embolized, or an intracardiac abscess specimen
Pathologic lesions showing active IE: vegetation or intracardiac abscess confirmed by 
histologic examination 
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IE
 
Typical microorganisms consistent 
with IE from 2 separate blood culture
• Viridans streptocci 
• Streptococcus bovis 
• HACEK group 
• Staphylococcus aureus 
• Community-acquired enteroccoci in 
the absence of a primary focus 
Microorganisms consistent with IE 
from persistently positive blood 
culture  
At least 2 positive cultures of blood 
samples drawn > 12h apart 
All of 3 or a majority of ≥ 4 separate 
cultures of blood (with first and last sample 
drawn at least 1h apart) 
Single positive blood culture for Coxiella burnettii or antiphase I IgG antibody titer 
>1:800 
E
v
id
e
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f 
e
n
d
o
b
a
ct
e
ri
a
l 
in
v
o
lv
m
e
n
t 
Echocardiogram positive for IE 
TEE recommended in patients with 
prosthetic valves rated at least 
“possible IE” by clinical criteria or 
complicated IE (paravalvular abscess)
TTE as first test in  others patients 
Oscillating intracardiac mass on valve or 
supporting structures in the path of 
regurgitant jets or on implanted material in 
the absence of an alternative anatomic 
explanation 
Abscess 
New partial dehiscence of prosthetic valve 
New valvular regurgitation (worsening or changing of pre-existing murmur not 
sufficient) 
M
in
o
r 
cr
it
er
ia
 
Predisposition, predisposing heart condition or injection drug use 
Fever, temperature >38°C 
Vascular phenomena, major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, 
intracranial hemorrhages, Janeway’s lesion 
Immunologic phenomena: glomerulonephritis, Osler’s nodes, Roth’s spots, rheumatic 
factor 
Microbiological evidence: positive blood culture but does not meet a major criterion, 
serological evidence of active infection with organism consistent with IE 
Definition of IE 
Definite IE Pathologic criteria ≥1
Clinical criteria 2 major criteria 
1 major + 3 minor criteria 
5 minor criteria 
Possible IE 1 major + 1 minor criteria 
3 minor criteria 
Rejected  Firm alternative diagnosis explaining evidence of IE 
Resolution of IE syndrome with antibiotic therapy for ≤ 4 days 
No pathologic evidence of IE at surgery or autopsy, with antibiotic therapy for ≤ 4 
days 
Does not meet criteria for possible IE as above 
Table 4. Modified Duke criteria (Li, 1999) (TEE: transesophageal echocardiography; TTE: 
transthoracic echocardiography) 
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Perivalvular complications should be suspected in case of persistent fever, unexplained or 
occurrence of atrioventricular block. They included abscess (most common in aortic and 
prosthesis IE), pseudoaneurysms, fistulae and signed uncontrolled infection. Staphylococcus 
aureus is most often implicated. Despite surgical treatment, 41% of patients die during 
hospitalization (ESC, 2009). 
6.1.2 Uncontrolled infection 
Resistant microorganisms, persisting systemic infection, other sites of infection, septic shock 
etc … can explain locally uncontrolled infection leading to acute coronary syndrome and 
third degree atrioventricular block. Indication of surgery should be discussed in these cases. 
Persisting fever, after 7-10 days of antibiotherapy, may discuss uncontrolled infection, 
adverse reaction to antibiotic, perivalvular complication, thrombosis, emboli… A complete 
infectious investigation with blood sample examination and intravenous line replacement 
and cultures, should be performed as well as echocardiography.  
6.1.3 Systemic embolism  
Migration of cardiac vegetations is responsible for systemic embolism (20-50% of IE) mainly 
in brain and spleen in left-sided IE and lung in native right-sided and pacemaker lead IE 
(ESC, 2009). However, all organs can be affected in case of patent foramen ovale. Embolisms 
are not uncommonly silent (20%) and often life-threatening. The incidence of embolic events 
increases during the first 2 weeks after the onset of antibiotherapy. Risk factors of embolism 
are individualized (Table 5) and prompt antibiotherapy can limit its occurrence (Thuny, 
2005). Addition of antithrombotic therapy (thrombolytic drugs, anticoagulant or antiplatelet 
therapy) doesn’t appear helpful in preventing whereas cardiac surgery during the first week 
of antibiotherapy (embolic risk peak) seems beneficial. 
 
Risk factors of embolism 
Vegetation 
characteristics 
Location  Mitral valve 
Multivalvular IE 
Size  >10mm 
Mobility  Increasing or decreasing under 
antibiotherapy 
Microorganisms  Bacteria  Staphylococci 
Streptococcus bovis 
Fungi  Candida spp 
Past history Previous embolism 
Biology Elevated C-reactive protein  
Table 5. Risk factors of embolism in IE (Durante Mangoni, 2003; ESC, 2009) 
6.1.4 Neurological complications  
Neurological damages after vegetation embolism are observed in 20 to 40 % of IE, mainly 
due to Staphylococcus aureus infection. These complications include stroke, infectious 
aneurysm (or mycotic aneurysm), brain abscess, meningitis, toxic encephalopathy and 
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seizure and are associated with poor prognosis (mainly ischaemic or haemorragic strokes) 
(ESC, 2009; Thuny, 2007). Cerebral imaging (computed tomography or better magnetic 
resonance imaging) should be performed in the presence of neurological signs or headaches 
(infectious aneurysm).  
Only poor neurological prognostic factors (coma, severe comorbidities and severe brain 
damage) can prohibit cardiac surgery (Table 5). In case of haemorragic stroke, cardiac 
surgery must be postponed for at least 1 month. In emergency cardiac situation, cooperation 
with neurosurgeon is mandatory. The best way to prevent these complications is to quickly 
start antibiotherapy (ESC, 2009).  
For patients with previous antithrombotic treatment and in the absence of stroke, oral 
anticoagulant therapy should be replaced by unfractionned heparin for a period of 2 weeks, 
mainly in case of S. aureus IE (higher risk of bleeding). In case of an ischaemic stroke, the 
same schema of replacement is proposed. Anticoagulation has to be stopped in case of a 
haemorragic stroke and a mechanical valve; unfractionned heparin should be reinitiated as 
soon as possible. Previous antiplatelet therapy must be stopped only in the occurrence of 
major bleeding (ESC, 2009). 
6.1.5 Metastatic infection 
Infectious aneurysms (3% of IE) (AEPEI, 2002) are secondary to arterial septic embolism, 
mainly in the brain. Most of them are silent but rupture is associated with   poor prognosis. 
No predicting factor has been individualized, however treatment (neurosurgery or 
endovascular surgery) is proposed in case of large, enlarging or already ruptured 
aneurysms. After specific antibiotherapy, most of unruptured infectious aneurysms resolve. 
Systemic abscesses (other than cerebral) are rare and should be suspected in case of 
persistent fever and bacteremia. Clinical criteria and imaging investigation help to find the 
site of the infection s (tomography, ultrasound etc). Treatment can be completed by surgery 
or percutaneous drainage in case of partial response to antibiotics. All organs can be 
affected: spleen, bone (spondylodiscitis 3-15%) etc (ESC, 2009). 
6.1.6 Renal complications 
Acute renal failure is frequent (30%) but often reversible. Causes are multiple: 
glomerulonephritis by immune complex deposition, renal infarction, haemodynamic 
impairment and antibiotic or contrast agent toxicity (ESC, 2009). 
6.1.7 Recurrences: Relapses and re-infections  
Relapse is mainly observed after inadequate antibiotic treatment (insufficient duration, 
resistant microorganisms, empirical antibiotherapy in IE with negative blood culture) or 
persistent focus of infection. Conversely, re-infection is a new IE with different 
microorganism(s) and mainly includes patients with previous IE, intravenous drug abusers, 
prosthetic valve carriers and chronic dialysis patients. Re-infection increases risk of death 
and of valve surgery (ESC, 2009). 
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6.2 Mortality  
In-hospital mortality varies from 9.6 to 26%. Prognosis is influenced by many factors (Table 
6) but the mortality is higher (79%) in presence of heart failure associated with periannular 
complications and Staphylococcus infection (Chu, 2004; ESC, 2009). Operative mortality is 
also significant (16%) mainly in patients with prosthetic valves (Fayad, 2011). 
Predictors of a poor prognostic 
Patient 
characteristics 
Presence of 
complications 
Microorganisms Echocardiographic findings 
- Older age 
- Prosthetic 
valve IE 
- Previous IE (= 
reinfection) 
- Insulin-
dependent 
diabetes 
mellitus 
- Comorbidities 
- Heart failure 
- Renal failure 
- Stroke 
- Septic chock 
- Periannular 
complications  
- S. aureus 
- Fungi 
- Gram-
negative 
bacilli 
- Periannular complications 
- Severe left-side valve 
regurgitation 
- Low left-ventricular ejection 
fraction 
- Large vegetation 
- Severe prosthetic 
dysfunction 
- Premature mitral valve 
closure and other signs of 
elevated diastolic pressure 
Table 6. Predictors factor of a poor prognosis in IE (ESC, 2009) 
7. Treatment: Prolonged antimicrobial therapy and infectious source 
eradication 
7.1 Medical treatment  
Medical treatment should be started quickly after carrying out of bacteriological samples, in 
particular blood cultures (3 independent sets at 30 minutes intervals). Antimicrobial therapy 
is first empirical (Table 7) and as soon as possible, it is adapted to micro-organism 
sensitivity (ESC, 2009). In all the cases, this treatment should be prolongated for several 
weeks and toxicity should be followed-up. As soon as possible, portal of entry and 
complications should be found and treated. Symptomatic care is usual and classical. 
7.2 Surgical treatment  
Cardiac surgery is often necessary to treat or prevent complications or eradicate infectious 
sites (Table 8). Surgery is more frequently necessary in some types of IE such as native valve 
IE (87% of IE operated with 57% in aortic IE and 50% for mitral IE), Staphylococci and 
Streptococci IE (respectively 35 and 33% of IE operated) (Fayad, 2011).  
With the exception of an emergency, extracardiac infections must be eradicated before 
surgery. Coronary angiography is also recommended in patients at risk (men older than 40, 
post-menopausal women, patients with at least one cardiovascular risk factor or a history of 
coronary disease) excluding emergency or cases with large aortic vegetation (risk of 
dislodgment during examination). Repair and replacement of the valve are possible but the 
last technique is preferred in complex cases. Intra operative transoesophageal 
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echocardiography is precious to guide surgeons. The operative mortality is moderate (16%) 
and is more frequent with prosthetic valve carriers (ESC, 2009). 
Characteristics of patient
Antibiotherapy suggested for adults patients 
Association of 
antibiotics 
Dosage 
Duration 
(weeks) 
• Native 
valve or  
• Prosthetic 
valve 
since  
more 
than 12 
months  
 Ampicillin-
sulbactam IV 
12g/day (in 4 doses) 
4-6 
Gentamicin IV or IM 3mg/kg/day (in 2 or 3 doses) 4-6 
Allergy 
to β-
lactams 
Vancomycin IV 30mg/kg/day (in 2 doses) 4-6 
Gentamicin IV or IM 3mg/kg/day (in 2 or 3 doses) 4-6 
Ciprofloxacin  1000 mg/day (in 2 doses) po or 
4-6 800mg/day (in 2 doses) IV 
Prosthetic valve since 
less than 12 months 
Vancomycin IV 30mg/kg/day (in 2 doses) 6 
Gentamicin IV or IM 3mg/kg/day (in 2 or 3 doses) 2 
Rifampicin  po 1200mg/day (in 2 doses) 2 
Table 7. Proposed antibiotic regimens for initial empirical treatment (po: per os/ IM: 
intramuscular/ IV intravenous). Be careful with chronic use of gentamicin and vancomycin. 
Serum levels of these antibiotics should be measured once a week for both and additional 
renal function testing should be performed for gentamicin. 
7.3 Follow-up 
Complications are usual and should be searched for regularly. This requires a daily clinical 
examination during the first weeks. Electrocardiogram should be performed frequently 
(mainly in aortic or prosthesis IE) looking for new atrioventricular block or ischemia signs. 
Bacteriological samples should be analyzed until their negativity. Heart failure and death 
can occur after several months, so echocardiography is recommended in case of 
cardiological signs but also after antibiotic treatment and should be repeated regularly 
during the first year (at 1, 3, 6 and 12 months) (ESC, 2009).  
Recurrence is frequent. Consequently, patients should be informed about this risk and 
prevention rules should be applied closely. 
8. Prevention 
8.1 Antibiotic prophylaxis 
In recent years, antibiotic prophylaxis has become more and more limited. In fact, no 
antibiotic permit disappearance of bacteremia after at-risk at-risk procedures. Until now, no 
study has proven the benefit of prophylactic treatment in the prevention of IE. At present, 
only antibiotic prophylaxis is recommended by ESC (ESC, 2009) for highest risk dental 
procedures in patients with highest risk cardiac conditions (Table 9). AHA (AHA, 2007) also 
recommends antibiotic prophylaxis for procedures on the respiratory tract or on infected 
skin in patients with highest risk of IE. Prophylaxis is associated with a small risk of death 
by anaphylaxis but no case has been reported to date and the main risk is microbial 
resistance development. 
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Indica-
tions 
Location of IE 
Left-sided native valve IE Prosthetic valve IE (PVE) Right-sided IE 
H
e
a
rt
 c
o
m
p
li
ca
ti
o
n
s 
H
ea
rt
 f
ai
lu
re
 
 
 
 
 
 
 
+ 
Severe acute regurgitation or 
valve obstruction causing 
refractory oedema pulmonary or 
cardiogenic shock 
Severe prosthetic 
dysfunction (dehiscence or 
obstruction) 
 
 
 
Right heart 
failure 
secondary to 
severe tricuspid 
regurgitation 
with poor 
response to 
diuretic therapy 
Emergency Emergency 
Fistula into a cardiac chamber or pericardium causing 
refractory pulmonary oedema or shock 
Emergency 
Severe acute regurgitation or 
valve obstruction and persisting 
heart failure or 
echocardiographic signs of poor 
haemodynamic tolerance (early 
mitral closure or pulmonary 
hypertension) 
Severe prosthetic 
dysfunction and persisting 
heart failure 
Urgent Urgent 
 
- 
Severe regurgitation and no heart 
failure 
Severe prosthetic dehiscence 
without heart cardiac 
 
Elective Elective 
U
n
co
n
tr
o
ll
e
d
 i
n
fe
ct
io
n
 
Locally uncontrolled infection (abscess, false aneurysm, fistula, 
enlarging vegetation) 
 
Microorganism
s difficult to 
eradicate 
(persistent 
fungi…) or 
bacteremia for 
> 7 days (S. 
aureus, P. 
aeruginosa…) 
Urgent 
Persisting fever and positive blood cultures > 7-10 days 
Urgent 
Fungi or multiresistant organisms 
Urgent / Elective 
 Staphylococci or Gram 
negative bacteria (most of 
cases of early PVE) 
Urgent/Elective 
P
re
v
e
n
ti
o
n
 o
f 
e
m
b
o
li
sm
 
Large vegetation (>10mm) 
following one or more embolic 
episodes despite appropriate 
antibiotic therapy 
Recurrent emboli despite 
appropriate antibiotic 
treatment 
Persistent 
tricuspid valve 
vegetation > 
20mm after 
recurrent 
pulmonary 
emboli with or 
without 
concomitant 
heart failure 
Urgent Urgent 
Large vegetation (>10mm) and other predictors of complicated 
course  
(heart failure, persistent infection, abscess) 
Urgent 
Isolated very large vegetation (>15mm) 
Urgent 
Table 8. Indications and timing of surgery (ESC, 2009). Emergency: within 24 hours. Urgent: 
within a few days. Elective: after 1 -2 weeks of antibiotic treatment. 
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Cardiac conditions at highest risk of IE Dental procedures at high risk 
• Prosthetic cardiac valve or material used for 
cardiac valve repair 
• Previous IE 
• Some congenital heart disease (CHD) 
• Cyanotic CHD  
- without surgical repair or 
- with residual defects, palliative shunts or 
conduits 
• CHD with complete repair with prosthetic 
material whether placed by surgery or by 
cutaneous technique, up to 6 months after 
the procedure 
• CHD when a residual defect persists at 
the site of implantation of a prosthetic 
material or device by cardiac surgery or 
percutaneous technique 
• Manipulation of  gingival region 
• Manipulation of periapical region of 
the teeth 
• Perforation of oral mucosa 
Antibiotic prophylaxis 
Single dose 30-60 minutes before 
procedure 
• Adults 
• Amoxicill
in 2g po 
or IV 
• If allergy: 
Clindamy
cin 600mg 
po or IV 
• Children 
• Amoxicilli
n 
50mg/kg 
po or IV 
• If allergy: 
Clindamy
cin 
20mg/kg 
po or IV 
 
Table 9. Recommendations for antibiotic prophylaxis of IE for patients undergoing dental 
procedures (ESC, 2009) (po: per os/ IV: intravenous) 
8.2 Hygienic rules  
Most IE occurs without history of procedure more at-risk situation of bacteremia (Strom, 
1998).  
Daily activities like chewing or tooth brushing carry transient but significant bacteremia and 
can cause IE (AHA, 2007). Consequently, it is recommended to maintain a good oral hygiene 
for all population. 
For patients and drug users, disposable intravenous material is mandatory.  
8.3 Others rules 
In medical practice, percutaneous iatrogenic procedures should be avoided especially on 
skin injuries and topical corticosteroid should be used with caution. Regular bacteriological 
skin analysis is recommended during the follow-up of erosive dermatosis because it allows 
quick adapted antibiotherapy in the case of secondarily advent IE. Of course, all prospective 
portals of entry and all comorbidities have to be searched and supported. 
9. Conclusion 
Infective endocarditis (IE) is a severe disease the diagnosis of which remains difficult due to 
clinical polymorphism and frequent insidious evolution over several days or months. Skin 
manifestations are very useful for diagnosis but should alert practitioners for presence of 
embolic complications. Epidemiologic profile of IE has changed in recent years and so has 
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prophylactic and therapeutic recommendations. IE concerns all practitioners and we have to 
keep it in mind with any patient.  
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